Novel 1,2-diarylcyclobutenes: Selective and orally active COX-2 inhibitors.

被引：0

作者：

Frenette, R ^{[1
]}

Friesen, RW ^{[1
]}

Dube, D ^{[1
]}

Fortin, R ^{[1
]}

Prescott, S ^{[1
]}

Cromlish, W ^{[1
]}

Greig, G ^{[1
]}

Kargman, S ^{[1
]}

Wong, E ^{[1
]}

CHan, CC ^{[1
]}

Gordon, R ^{[1
]}

Xu, L ^{[1
]}

Riendeau, D ^{[1
]}

机构：

[1] MERCK FROSST CANADA INC,MERCK FROSST CTR THERAPEUT RES,POINTE CLAIRE,PQ H9R 4P8,CANADA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 213卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：70 / MEDI

页数：1

共 50 条

[1] Novel 1,2-diarylcyclobutenes: Selective and orally active COX-2 inhibitors
Friesen, RW
Dube, D
Fortin, R
Frenette, R
Prescott, S
Cromlish, W
Greig, GM
Kargman, S
Wong, E
Chan, CC
Gordon, R
Xu, LJ
Riendeau, D
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) : 2677 - 2682
[2] Potent, selective, and orally active second generation COX-2 inhibitors.
Roy, PJ
Brideau, C
Chan, C
Charleson, S
Cromlish, W
Ethier, D
Evans, J
Ford-Hutchinson, A
Greig, G
Gresser, M
Grimm, E
Guay, J
Kargman, S
Leblanc, Y
Li, CS
O'Neill, G
Riendeau, D
Rodger, I
Wang, Z
Wong, E
Xu, L
Young, RN
Zamboni, R
Prasit, P
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
[3] SELECTIVE CYCLOOXYGENASE INHIBITORS - NOVEL 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY-ACTIVE COX-2 INHIBITORS
REITZ, DB
LI, JJ
NORTON, MB
REINHARD, EJ
COLLINS, JT
ANDERSON, GD
GREGORY, SA
KOBOLDT, CM
PERKINS, WE
SEIBERT, K
ISAKSON, PC
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) : 3878 - 3881
[4] SELECTIVE CYCLOOXYGENASE INHIBITORS - NOVEL 4-SPIRO 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY-ACTIVE COX-2 INHIBITORS
REITZ, DB
HUANG, HC
LI, JJ
GARLAND, DJ
MANNING, RE
ANDERSON, GD
GREGORY, SA
KOBOLDT, CM
PERKINS, WE
SEIBERT, K
ISAKSON, PC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) : 867 - 872
[5] Perception of risk: the state of COX-2 selective inhibitors.
Simon L.S.
Strand V.
Current Rheumatology Reports, 2005, 7 (3) : 163 - 166
[6] Structure based design of selective COX-2 inhibitors.
Browner, MF
FASEB JOURNAL, 1998, 12 (08): : A1304 - A1304
[7] Computational approach to find selective COX-2 inhibitors.
Kumar, M
Zauhar, RJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U528
[8] Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides
Tsai, Wei-Jern
Shiao, Young-Ji
Lin, Shwu-Jiuan
Chiou, Wen-Fei
Lin, Lie-Chwen
Yang, Tsang-Hsiung
Teng, Che-Ming
Wu, Tain-Shung
Yang, Li-Ming
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4440 - 4443
[9] Discovery of new class of potent and selective COX-2 inhibitors.
Wang, Z
Black, WC
Brideau, C
Chan, C
Charleson, S
Cromlish, W
Denis, D
Ethier, D
Evans, J
Falgueyret, JP
FordHutchinson, A
Gauthier, JY
Gordon, R
Greig, G
Gresser, M
Grimm, E
Guay, J
Leblanc, Y
Leger, S
Kargman, S
Mancini, J
ONeill, G
Ouellet, M
Percival, D
Prasit, P
Riendeau, D
Rodger, I
Skorey, K
Tagari, P
Therien, M
Wong, E
Young, RN
Xu, L
Zamboni, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 16 - MEDI
[10] Design and synthesis of novel benzo-dioxolane cyclooxygenase (COX-2) selective inhibitors.
Ezawa, M
Khanapure, SP
Garvey, DS
Young, D
Earl, RA
Gaston, RD
Fang, XQ
Marek, P
Shumway, M
Trocha, M
Janero, DR
Letts, LG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U217 - U218

← 1 2 3 4 5 →